Concepedia

Ziad Younes

ZY

Statistics

Publications

56

Citations

8.6K

H-Index

33

Active since

1999

Affiliations

Gastro One (United States)(Current)

Texas Liver Institute

The University of Texas at San Antonio Health Science Center

University of California San Diego

Gilead Sciences (United States)

Ziad Younes is an author at Gastro One (United States) specializing in pharmacotherapy, medicine, and virology.

ORCID

Publications per year

1999–2024

56

Publications

56

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations

, , +12

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

, , +8

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Péter Ferenci, David Bernstein, Jacob Lalezari et al. · New England Journal of Medicine · 2014 · 695 citations · Full text

, , +16

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

David R. Nelson, James N. Cooper, Jacob Lalezari et al. · Hepatology · 2015 · 689 citations · Full text

, , +15

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

Marc Bourlière, Stuart C. Gordon, Steven L. Flamm et al. · New England Journal of Medicine · 2017 · 565 citations

, , +15

1–5 of 56